Noronha Glenn 4
4 · Clearside Biomedical, Inc. · Filed Dec 12, 2017
Insider Transaction Report
Form 4
Noronha Glenn
Chief Scientific Officer
Transactions
- Award
Employee Stock Option (right to buy)
2017-12-08+96,000→ 96,000 totalExercise: $5.89Exp: 2027-12-07→ Common Stock (96,000 underlying)
Footnotes (1)
- [F1]One-fourth of the shares underlying this option vest on December 8, 2018 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date.